IP Library Granted Patent US 9,463,241
Granted Patent B2
US 9,463,241 · App. 13/752,189 · Granted Oct 11, 2016

Method for stabilising an immunoglobulin G composition in liquid form

Inventors: Annie Bardat (Limours, FR); Edith Begin (Les Ulis, FR); Nassirah Khandoudi (Les Ulis, FR); Olivier Just (Marcoussis, FR); Sami Chtourou (Elancourt, FR); Roland Schmitthaeusler (Montigny le Bretonneux, FR)
Assignee: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
A61K39/395A61K39/39591
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,463,241
App. No.
13/752,189
Granted
Oct 11, 2016
Kind
B2
Abstract

This invention is related to a stabilizing formulation for immunoglobulins G compositions comprising a sugar alcohol, glycine and a non-ionic detergent, which is suitable for the stabilization of immunoglobulins G compositions in liquid form and in lyophilized form. The invention also relates to an immunoglobulins G composition in liquid form or in lyophilized form comprising said stabilizing formulation.

Claims (16)

1. A method of stabilising a polyclonal immunoglobulin G composition in liquid form obtained directly by fractioning of human plasma, said method comprising combining said polyclonal immunoglobulin G (IgG) composition with a stabilising formulation for IgG compositions, wherein the formulation consists of a sugar alcohol, glycine, and a non-ionic detergent.

2. A method of stabilising a polyclonal immunoglobulin G composition in lyophilised form, said method comprising combining said polyclonal immunoglobulin G composition with a stabilising formulation for IgG compositions, wherein the formulation consists of a sugar alcohol, glycine, and a non-ionic detergent.

3. A method of stabilising a polyclonal immunoglobulin G composition in liquid form obtained after reconstitution in a suitable aqueous medium of an immunoglobulin G composition in lyophilised form, said method comprising combining said polyclonal immunoglobulin G composition with a stabilising formulation for IgG compositions, wherein the formulation consists of a sugar alcohol, glycine, and a non-ionic detergent.

4. The method of stabilising a polyclonal immunoglobulin G composition according to any one of claims 1 to 3 , wherein the formulation consists in the said sugar alcohol, glycine and non-ionic detergent.

5. The method of stabilising a polyclonal immunoglobulin G composition according to claim 4 , wherein the sugar alcohol is mannitol.

6. The method of stabilising a polyclonal immunoglobulin G composition according to claim 5 , wherein the concentration of mannitol is between 30 g/l and 50 g/l.

7. The method of stabilising a polyclonal immunoglobulin G composition according to claim 4 , wherein the concentration of glycine is between 7 g/l and 10 g/l.

8. The method of stabilising a polyclonal immunoglobulin G composition according to claim 4 , wherein the concentration of the non-ionic detergent is between 20 and 50 ppm.

9. The method of stabilising a polyclonal immunoglobulin G composition according to claim 1 , wherein the composition includes an amount of polymers less than 0.3% after a 6 month storage period at room temperature.

10. The method of stabilising a polyclonal immunoglobulin G composition according to claim 2 , wherein the composition includes an amount of polymers less than 0.3% after a 12 month storage period at room temperature for 6 months at 40° C.

11. The method of stabilising a polyclonal immunoglobulin G composition according to any one of claims 1 to 3 , wherein the composition includes an amount of dimers less than 7% after a 24 month storage period at 4° C.

12. The method of stabilizing a polyclonal immunoglobulin G composition according to any one of claims 1 to 3 , wherein the formulation consists of a sugar alcohol in a concentration of between 30 g/l and 50 g/l, glycine in a concentration of between 7 g/l and 10 g/l, and a non-ionic detergent.

13. The method of stabilizing a polyclonal immunoglobulin G composition according to any one of claims 1 to 3 , wherein the formulation consists of a sugar alcohol in a concentration of between 30 g/l and 50 g/l, glycine in a concentration of between 7 g/l and 10 g/l, and a non-ionic detergent in a concentration of between 20 and 50 ppm.

14. The method of stabilizing a polyclonal immunoglobulin G composition according to any one of claims 1 to 3 , wherein the formulation consists of mannitol, glycine, and a non-ionic detergent.

15. The method of stabilizing a polyclonal immunoglobulin G composition according to any one of claims 1 to 3 , wherein the formulation consists of 50 g/l mannitol, 10 g/l glycine, and 50 ppm polysorbate 80 (non-ionic detergent).

16. The method of stabilizing a polyclonal immunoglobulin G composition according to any one of claims 1 to 3 , wherein the formulation consists of 50 g/l mannitol, 10 g/l glycine, and 50 ppm octoxinol 10 (non-ionic detergent).

Assignments (4)
CHANGE OF OWNER/APPLICANT'S ADDRESS Recorded Apr 3, 2023
From: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 063237/0439 →
CHANGE OF OWNER/APPLICANT'S ADDRESS Recorded Sep 21, 2022
From: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 061493/0885 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 029909 FRAME 0250. ASSIGNOR(S) HEREBY CONFIRMS THE NAME OF THE ASSIGNEE IS LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES. Recorded Oct 30, 2018
From: BARDAT, ANNIE; BEGIN, EDITH; KHANDOUDI, NASSIRAH; JUST, OLIVIER; CHTOUROU, SAMI; SCHMITTHAEUSLER, ROLAND
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 047363/0898 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2013
From: BARDAT, ANNIE; BEGIN, EDITH; KHANDOUDI, NASSIRAH; JUST, OLIVIER; CHTOUROU, SAMI; SCHMITTHAEUSLER, ROLAND
To: LABORATORIE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 029909/0250 →
Priority Claims (1)
FR 03 04388 · Apr 9, 2003 · national
Continuity (2)
Division 10552314
Related Publication 20130202585A1 · Aug 8, 2013